May 3rd 2024
Results showed 46.45 and 72.74% increases in the global incidences of acute infection and HCV-related cirrhosis, respectively, in reproductive-age women.
Study Highlights Efficacy of ALT/HDL-C Ratio as Biomarker for NAFLD
September 22nd 2023Investigators suggested an ALT/HDL-C ratio of 15.97 as a screening threshold for identifying NAFLD, noting its increased effectiveness compared to ALT, HDL-C, the aspartate aminotransferase to HDL-C ratio, and the gamma-glutamyl transferase to HDL-C ratio.
Noninvasive ABDA Score Predicts Fibrotic NASH
September 15th 2023Investigators developed the identification model based on significantly associated factors of fibrotic NASH and tested it in derivation and validation cohorts, where it identified 89.9% and 81.0% of patients with fibrotic NASH, respectively.
Physical Activity, Television Viewing Linked to NAFLD Prevalence
September 13th 2023The study's findings show an association between NAFLD prevalence, physical activity, and television viewing, with higher levels of physical activity paired with lower levels of television viewing leading to a statistically significantly reduced risk of NAFLD.
Biomarker Panels Meet Criteria for Diagnostic Enrichment Qualification in Stage 1 of NIMBLE Project
September 8th 2023Performance metrics of NIS4, the ELF test, and FibroMeter VCTE met prespecified criteria for qualification for regulatory approval in stage 1 of the NIMBLE project's circulating biomarker workstream.
Endocrine Case Report: Diarrhea and Weight Loss
September 5th 2023This endocrine case report from Brady Pregerson, MD, features a patients in his mid-70s with a history of hypothyroidism presenting with weeks of nausea, vomiting, and diarrhea without blood but with a 30-pound weight loss. Can you determine the most likely diagnosis?
HCV-Infected Liver Transplant Patients Benefit from DAA Use, Study Finds
September 2nd 2023Results from the retrospective cohort study indicated viral eradication with DAAs after liver transplantation improved liver function and patient survival after a long-term follow-up, even in cirrhotic patients.